Development of Sialic Acid-coated Nanoparticles for Targeting Cancer and Efficient Evasion of the Immune System

Theranostics. 2017 Feb 23;7(4):962-973. doi: 10.7150/thno.19061. eCollection 2017.

Abstract

Evading the reticuloendothelial system (RES) remains a critical challenge in the development of efficient delivery and diagnostic systems for cancer. Sialic acid (N-acetylneuraminic acid, Neu5Ac) is recognized as a "self" marker by major serum protein complement factor H and shows reduced interaction with the innate immune system via sialic acid-binding immunoglobulin-like lectin (Siglec), which is known as one of the significant regulators of phagocytic evasion. Accordingly, we prepared different surface-modified gold nanoparticles (AuNPs) and investigated the effects of sialic acid on cellular and immune responses of nanoparticles in vitro and in vivo. Sialic acid modification not only facilitates evasion of the RES by suppressing the immune response, but also enhances tumor accumulation via its active targeting ability. Therefore, sialic acid modification presents a promising strategy to advance nanotechnology towards the prospect of clinical translation.

Keywords: Neu5Ac); anti-recognition effect; evading phagocytosis; lectin targeting; molecular imaging; positron emission tomography (PET).; sialic acid (N-acetylneuraminic acid.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / drug therapy
  • Disease Models, Animal
  • Gold / administration & dosage
  • Gold / metabolism*
  • Immune System / metabolism*
  • Mice
  • Molecular Imaging
  • N-Acetylneuraminic Acid / administration & dosage
  • N-Acetylneuraminic Acid / metabolism*
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry*
  • Nanoparticles / metabolism*
  • Positron-Emission Tomography
  • RAW 264.7 Cells
  • Staining and Labeling

Substances

  • Gold
  • N-Acetylneuraminic Acid